diallyl trisulfide has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HM; Lu, ZY; Yan, JC; Yang, HB | 1 |
| Liu, YY; Nie, XM; Shi, DM; Su, LX; Zhao, YX; Zhou, YJ; Zhou, ZM | 1 |
1 trial(s) available for diallyl trisulfide and Diabetic Angiopathies
| Article | Year |
|---|---|
[Effects of allitridi capsules on endothelial function and clinical prognosis after percutaneous coronary intervention in coronary artery disease patients with diabetes mellitus].
Topics: Aged; Allyl Compounds; Capsules; Coronary Artery Disease; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Nitric Oxide; Percutaneous Coronary Intervention; Postoperative Period; Sulfides | 2013 |
1 other study(ies) available for diallyl trisulfide and Diabetic Angiopathies
| Article | Year |
|---|---|
Effect of Diallyl Trisulfide on Ischemic Tissue Injury and Revascularization in a Diabetic Mouse Model.
Topics: Allyl Compounds; Angiogenesis Inducing Agents; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hindlimb; Ischemia; Male; Mice, Inbred C57BL; Muscle, Skeletal; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Carbonylation; Regional Blood Flow; Sulfides; Vascular Endothelial Growth Factor A | 2018 |